Form 4 for PCSA Processa Pharmaceuticals, Inc.
Accepted 2024-08-02 00:00:00 ET · period of report 2024-04-05 · accession 0000897069-24-001608 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-02 | 2024-04-05+ | PCSA | Guy Wendy | Chief Administrative Off | F - Tax | $2.39 | -588 | 11.4K | -5% | -$1,403 |
| DM | 2024-08-02 | 2024-04-05+ | PCSA | Guy Wendy | Chief Administrative Off | M - OptEx | — | +2,319 | 11.8K | +24% | — |
| DM | 2024-08-02 | 2024-06-28 | PCSA | Guy Wendy | Chief Administrative Off | A - Grant | $0.00 | +5,426 | 24.2K | +29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-10 | F | D | 220 | $1.71 | 11,857 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-10 | M | A | 644 | — | 12,077 | D | — | — | (F1) Distribution of vested restricted shares. |
| 3 | Common | Common Stock | 2024-04-05 | F | D | 368 | $2.79 | 11,433 | D | — | — | |
| 4 | Common | Common Stock | 2024-04-05 | M | A | 1,675 | — | 11,801 | D | — | — | (F1) Distribution of vested restricted shares. |
| 5 | Derivative | Restricted Stock Units | 2024-06-28 | A | A | 339 | $0.00 | 24,914 | D | $0.00 · — to — | 339 Common Stock | (F4) Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals. |
| 6 | Derivative | Restricted Stock Units | 2024-06-28 | A | A | 2,713 | $0.00 | 22,201 | D | $0.00 · — to — | 2,713 Common Stock | (F2) Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on January 1, 2025. |
| 7 | Derivative | Restricted Stock Units | 2024-06-28 | A | A | 339 | $0.00 | 24,575 | D | $0.00 · — to — | 339 Common Stock | (F4) Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals. |
| 8 | Derivative | Restricted Stock Units | 2024-06-28 | A | A | 2,035 | $0.00 | 24,236 | D | $0.00 · — to — | 2,035 Common Stock | (F3) Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2025, and one-thirty-sixth each month thereafter until fully vested on January 1, 2027. |